Cargando…

Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds

Ene-reductases from the ‘Old Yellow Enzyme’ family of flavoproteins catalyze the asymmetric reduction of various α,β-unsaturated compounds at the expense of a nicotinamide cofactor. They have been applied to the synthesis of valuable enantiopure products, including chiral building blocks with broad...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Christoph K., Tasnádi, Gábor, Clay, Dorina, Hall, Mélanie, Faber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521962/
https://www.ncbi.nlm.nih.gov/pubmed/22498437
http://dx.doi.org/10.1016/j.jbiotec.2012.03.023
_version_ 1782253023254282240
author Winkler, Christoph K.
Tasnádi, Gábor
Clay, Dorina
Hall, Mélanie
Faber, Kurt
author_facet Winkler, Christoph K.
Tasnádi, Gábor
Clay, Dorina
Hall, Mélanie
Faber, Kurt
author_sort Winkler, Christoph K.
collection PubMed
description Ene-reductases from the ‘Old Yellow Enzyme’ family of flavoproteins catalyze the asymmetric reduction of various α,β-unsaturated compounds at the expense of a nicotinamide cofactor. They have been applied to the synthesis of valuable enantiopure products, including chiral building blocks with broad industrial applications, terpenoids, amino acid derivatives and fragrances. The combination of these highly stereoselective biocatalysts with a cofactor recycling system has allowed the development of cost-effective methods for the generation of optically active molecules, which is strengthened by the availability of stereo-complementary enzyme homologues.
format Online
Article
Text
id pubmed-3521962
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-35219622012-12-31 Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds Winkler, Christoph K. Tasnádi, Gábor Clay, Dorina Hall, Mélanie Faber, Kurt J Biotechnol Article Ene-reductases from the ‘Old Yellow Enzyme’ family of flavoproteins catalyze the asymmetric reduction of various α,β-unsaturated compounds at the expense of a nicotinamide cofactor. They have been applied to the synthesis of valuable enantiopure products, including chiral building blocks with broad industrial applications, terpenoids, amino acid derivatives and fragrances. The combination of these highly stereoselective biocatalysts with a cofactor recycling system has allowed the development of cost-effective methods for the generation of optically active molecules, which is strengthened by the availability of stereo-complementary enzyme homologues. Elsevier Science Publishers 2012-12-31 /pmc/articles/PMC3521962/ /pubmed/22498437 http://dx.doi.org/10.1016/j.jbiotec.2012.03.023 Text en © 2012 Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/3.0/Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Article
Winkler, Christoph K.
Tasnádi, Gábor
Clay, Dorina
Hall, Mélanie
Faber, Kurt
Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title_full Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title_fullStr Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title_full_unstemmed Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title_short Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
title_sort asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521962/
https://www.ncbi.nlm.nih.gov/pubmed/22498437
http://dx.doi.org/10.1016/j.jbiotec.2012.03.023
work_keys_str_mv AT winklerchristophk asymmetricbioreductionofactivatedalkenestoindustriallyrelevantopticallyactivecompounds
AT tasnadigabor asymmetricbioreductionofactivatedalkenestoindustriallyrelevantopticallyactivecompounds
AT claydorina asymmetricbioreductionofactivatedalkenestoindustriallyrelevantopticallyactivecompounds
AT hallmelanie asymmetricbioreductionofactivatedalkenestoindustriallyrelevantopticallyactivecompounds
AT faberkurt asymmetricbioreductionofactivatedalkenestoindustriallyrelevantopticallyactivecompounds